In spite of the munchies, using THC-rich cannabis is associated with lower weight and a smaller risk for Type II diabetes. This is well substantiated by human epidemiology and research. But it naively seems to contradict quite a bit of preclinical research on the role of the endocannabinoid system in metabolism, which has shown that activating the CB1 receptor promotes weight gain and reduces insulin sensitivity.
During the first week of July 2018, five-hundred-and-thirty-five delegates from five continents met at the University of Leiden in the Netherlands for the 28th annual symposium of the International Cannabinoid Research Society (ICRS). The four-day conference showcased recent scientific discoveries about cannabis components and various ways of targeting the endocannabinoid system to improve health outcomes.
Food is medicine. This delicious pumpkin curry recipe by Nature Going Smart is full of ingredients with powerful healing properties.
The endocannabinoid system regulates numerous physiological processes, including intestinal function, glucose metabolism, and stress response. New research discusses the roles of CB1 and CB2 cannabinoid receptors pertaining to diet, digestion, and energy metabolism.
Study shows marijuana users are much less likely to develop metabolic syndrome, a significant risk factor for obesity, diabetes, and heart disease.